Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The NIH site-transition announcement banner was removed from the page; the study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-11-07T15:36:03.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T16:13:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T19:23:01.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:41.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T21:53:34.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with added HTML header content, while multiple institution names and study-related terms were removed, reducing the visible details of the study record.
    Difference
    22%
    Check dated 2026-09-19T21:50:53.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.